/ CompletedNot ApplicableIIT Short-term Impact of Cyplexinol® on Inflammatory Status and Related Measures in Men and Women With Self-reported Joint Pain
In this study, the impact of 900 mg Cyplexinol® taken daily on joint pain over a period of 15 days in comparison with a placebo will be determined using a cross-over double blind design with a 13 day wash out period. In addition, we will measure cytokine production and related variables during the two hour after subjects ingest a single dosage of Cyplexinol® or placebo on days 1 and 15.
100 Clinical Results associated with ZyCal Bioceuticals Healthcare Co., Inc
0 Patents (Medical) associated with ZyCal Bioceuticals Healthcare Co., Inc
100 Deals associated with ZyCal Bioceuticals Healthcare Co., Inc
100 Translational Medicine associated with ZyCal Bioceuticals Healthcare Co., Inc